Protecting memory, preventing cardiovascular (CV) disease, and possibly extending life: Spermidine is marketed with broad health claims. This naturally occurring amine is of considerable biological interest. However, a significant gap remains between plausible antiaging mechanisms and proven clinical benefits. What does the evidence actually show?

Biological Role

Spermidine is a naturally occurring polyamine. Together with putrescine and spermine, it plays a role in fundamental cellular processes, including cell growth, translation, gene regulation, and protein homeostasis. The human body produces spermidine, which is also obtained through the diet. The gut microbiota also contributes to polyamine metabolism.

Significant amounts of spermidine are found in wheat germ and other whole-grain products, soybeans and other legumes, mushrooms, and aged cheeses. Various vegetables and other plant-based foods also contribute to dietary intake. However, the levels vary considerably according to the food, degree of ripeness, processing, and fermentation.

Blood Levels

The pharmacokinetics of spermidine appear to be more complex than expected. A randomized, placebo-controlled study found that even high oral doses of spermidine did not increase spermidine concentrations in the plasma or saliva. Instead, supplementation increased the plasma levels of spermine.

In another exploratory double-blind randomized controlled trial, 37 older men received 40 mg of spermidine daily or placebo. This study found only limited changes in circulating polyamine levels.

Antiaging Mechanisms

Autophagy is central to the current scientific interest in spermidine. During this lysosomal recycling process, cells break down damaged proteins and other cellular components. Preclinical studies have suggested that spermidine can influence autophagy.

Studies in yeast, worms, flies, and mice have also linked spermidine administration to changes in autophagy, CV aging, and, to some extent, lifespan. These findings provide a biological basis for further research but do not establish efficacy in humans. This remains a key limitation of spermidine research: Preclinical evidence is substantially stronger than clinical evidence.

Cognitive Outcomes

Manufacturers promote spermidine as a way to maintain cognitive function. However, the most significant randomized study to date has not provided convincing evidence to support this claim.

As part of the SmartAge study, 100 older adults with subjective cognitive decline received either a spermidine-rich supplement or placebo for 12 months. Researchers assessed several outcomes, including participants’ ability to distinguish previously viewed images from very similar new images. This fine-grained memory task is considered a sensitive marker of age-related changes in the hippocampus. Spermidine supplementation did not significantly improve the primary endpoint.

The primary intention-to-treat analysis also found no substantial benefit with spermidine compared with placebo across the secondary endpoints, including other memory and executive functions, quality of life, sleep, inflammatory and vascular markers, and CV parameters. Exploratory analyses identified several signals, including those related to verbal memory and inflammatory parameters. However, these exploratory findings did not confirm the effectiveness of spermidine.

The secondary endpoints, including other measures of memory and executive function, quality of life, sleep, inflammatory and vascular markers, and CV parameters, also showed no significant benefit compared with placebo in the primary intention-to-treat analysis. Exploratory analyses identified possible signals related to verbal memory and inflammatory markers; however, these findings did not establish efficacy.

A previous small study in patients with mild-to-moderate dementia reported an association between higher spermidine intake and better cognitive test results. However, the small sample size, study design, and lack of confirmation from larger, high-quality studies mean that this finding alone is insufficient to support treatment recommendations.

CV Health

Human studies have reported interesting findings regarding CV health and longevity. A prospective cohort study involving 829 individuals found an inverse association between estimated spermidine intake and all-cause mortality. For each SD increase in spermidine intake, the adjusted hazard ratio for all-cause mortality was 0.76. However, this is an association and not evidence of causality. Individuals who consume a spermidine-rich diet may differ in other dietary and lifestyle factors.

Another large prospective analysis using UK Biobank data examined whether dietary polyamine intake was associated with mortality and CV disease. Because the study was observational, it could not determine whether spermidine itself caused the observed health associations.

Biomarker Findings

A 2025 small pilot study provided initial biomarker signals. Twelve healthy adults received 1.5 or 3.3 mg of spermidine from rice germ extract daily for 56 days. Among participants who received 3.3 mg daily, the autophagy-associated markers Beclin 1 and ULK1 increased by 7.3% and 13.4%, respectively, while brain-derived neurotrophic factor increased by 12.1%. At the same dose, high-sensitivity C-reactive protein decreased by 20.8%, very low-density lipoprotein by 20.1%, and triglycerides by 26.9%.

From a mechanistic perspective, these changes point in a potentially beneficial direction and could help explain the potential protective effects. However, their clinical significance remains unclear. With only 12 participants, a 56-day observation period, and exclusively surrogate parameters, the researchers could not infer disease prevention or antiaging effects from these findings.

Safety Profile

The spermidine supplements studied to date appear to be generally well tolerated in the short- to medium-term. A safety study involving older adults found no significant differences compared with placebo in vital signs, weight, clinical chemistry, hematologic parameters, or subjective health status. In the 12-month SmartAge randomized controlled trial, adverse events were similar among participants receiving spermidine and those receiving placebo.

Large studies involving years of supplementation are lacking, and the existing sample sizes are too small to reliably exclude rare adverse effects.

Drug Interactions

To date, no well-characterized clinical drug interactions involving spermidine supplements have been identified in large studies conducted in humans. However, this does not mean that relevant interactions can be ruled out; rather, they have not been adequately investigated.

Polyamines are biologically active molecules. Their metabolism is closely linked to cell growth, protein synthesis, and various signaling pathways. Therefore, caution is warranted in patients with cancer, especially those receiving drug-based cancer treatment. Polyamine metabolism and strategies for its modification are also being investigated as therapeutic targets in oncology. Although no harmful interactions with spermidine supplements have been established, experts advise against indiscriminate supplementation, particularly in patients with breast cancer.

Clinical Implications

Spermidine is an intriguing candidate for longevity. Biological mechanisms are plausible, animal studies have shown promising results, and epidemiologic data are of interest. However, convincing evidence of a clinically relevant benefit of spermidine supplementation in humans is still lacking. On the basis of current evidence, no patient group can be unequivocally recommended spermidine supplementation for the prevention or treatment of disease.

A different assessment applies to diets that include foods containing spermidine, such as whole-grain products, legumes, and vegetables. Regardless of their spermidine content, these foods are valuable components of a healthy diet. However, the available observational data cannot establish whether any health benefits are specifically attributable to the spermidine they contain.

This story was translated from Medscape’s German edition.